MARKET NEWS

XOMA’s Royalty Portfolio Grows With Addition of Three Royalty Assets
CordenPharma Colorado Expands Lipid Excipients Purfication 
New Biomaterial Regrows Blood Vessels & Bone According to RCSI Research
Longeveron Announces Successful Completion of Phase 1/2 Clinical Study 
LEXEO Therapeutics Announces FDA Fast-Track Designation
Catalent Adds Cryogenic Capabilities at Philadelphia Clinical Supply Services Facility to Meet Growing Demand for Cell & Gene Therapy Development

  FEATURED EDITORIAL


  COMPANY PROFILE

Proveris Scientific is a leader in analytical instruments for spray and aerosol product testing and contract services. Trusted partner in product development from early stage R&D to manufacturing. Serving pharmaceutical companies, device manufacturers, CDO/CRO/CMOs, and regulatory agencies. Click here for more.


VIDEO SPOTLIGHT – Aji Bio-Pharma Animated Fill Finish Capabilities

  EXCLUSIVE ONLINE CONTENT


MacroGenics Adopts Genedata Profiler to Enhance Development of Immunotherapies 

MacroGenics Adopts Genedata Profiler to Enhance Development of Immunotherapies 

Genedata recently announced a long-term partnership agreement with MacroGenics, a biopharmaceutical company and an emerging leader in developing and commercializing innovative immune-oncology therapeutics…..

Agenus Submits Balstilimab Biologics License Application to the US FDA for Patients With Recurrent or Metastatic Cervical Cancer

Agenus Submits Balstilimab Biologics License Application to the US FDA for Patients With Recurrent or Metastatic Cervical Cancer

Agenus Inc. recently announced the submission of a Biologics License Application (BLA) to the US FDA for the accelerated approval of….

ERS Genomics & NUVISAN ICB Sign CRISPR/Cas9 License Agreement

ERS Genomics & NUVISAN ICB Sign CRISPR/Cas9 License Agreement

ERS Genomics Limited and NUVISAN Innovation Campus Berlin (ICB) GmbH recently announced a non-exclusive license agreement granting NUVISAN ICB access to….

CureVac Swiss AG Initiates Rolling Submission Process for mRNA-Based COVID-19 Vaccine Candidate

CureVac Swiss AG Initiates Rolling Submission Process for mRNA-Based COVID-19 Vaccine Candidate

The CureVac Swiss AG, the Swiss subsidiary of CureVac N.V. recently announced initiation of a rolling submission for CVnCoV, the company’s mRNA-based COVID-19 vaccine….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

May 5 – Prefilled Syringes
May 10 – Particle Design Technology